Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Equivalence of Boosted Atazanavir Based Regimens and Currently Effective HAART Regimens With Other PI's/NNRTI's in HIV+ Children and Adolescents With Elevated Lipid Levels

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT00940771
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:37:44.379207+00:00
Published At
2020-04-20T00:00:00+00:00
Record Updated At
2020-04-20
Results Posted At
2020-04-20
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Pediatric HIV", "HIV Infections"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2020-04-20"
protocolSection.identificationModule.nctId
"NCT00940771"
protocolSection.identificationModule.officialTitle
"Equivalence of Boosted Atazanavir Based Regimens and Currently Effective HAART Regimens With Other PI\u0027s/NNRTI\u0027s in HIV+ Children and Adolescents With Elevated Lipid Levels"
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
["PHASE4"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
"2020-04-20"

Study condition terms

  • Pediatric HIV (protocolSection.conditionsModule.conditions)
  • HIV Infections (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.